Prediction and Evaluation of Protein Aggregation with Computational Methods

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2024 Nov 22

PMID 39576588

Authors

Mubashir Hassan

Saba Shahzadi

Mai Suan Li

Andrzej Kloczkowski

Affiliations

Soon will be listed here.

Abstract

Protein and peptide aggregation has recently become one of the most studied biomedical problems due to its central role in several neurodegenerative disorders and of biotechnological importance. Multiple in silico methods, databases, tools, and algorithms have been developed to predict aggregation of proteins and peptides to better understand fundamental mechanisms of various aggregation diseases. Here, we attempt to provide a brief overview of bioinformatic methods and tools to better understand molecular mechanisms of aggregation disorders. Furthermore, through a better understanding of protein aggregation mechanisms, it might be possible to design novel therapeutic agents to treat and hopefully prevent protein aggregation diseases.

References

Thul P, Lindskog C . The human protein atlas: A spatial map of the human proteome. Protein Sci. 2017; 27(1):233-244. PMC: 5734309. DOI: 10.1002/pro.3307. View

Toyama B, Hetzer M . Protein homeostasis: live long, won't prosper. Nat Rev Mol Cell Biol. 2012; 14(1):55-61. PMC: 3570024. DOI: 10.1038/nrm3496. View

Diaz-Villanueva J, Diaz-Molina R, Garcia-Gonzalez V . Protein Folding and Mechanisms of Proteostasis. Int J Mol Sci. 2015; 16(8):17193-230. PMC: 4581189. DOI: 10.3390/ijms160817193. View

Tanzi R, Bertram L . Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005; 120(4):545-55. DOI: 10.1016/j.cell.2005.02.008. View

Ye S, Hsiung C, Tang Y, Zhang X . Visualizing the Multistep Process of Protein Aggregation in Live Cells. Acc Chem Res. 2022; 55(3):381-390. PMC: 9098262. DOI: 10.1021/acs.accounts.1c00648. View

De Felice F, Vieira M, Meirelles M, Morozova-Roche L, Dobson C, Ferreira S . Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure. FASEB J. 2004; 18(10):1099-101. DOI: 10.1096/fj.03-1072fje. View

Nguyen P, Ramamoorthy A, Sahoo B, Zheng J, Faller P, Straub J . Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis. Chem Rev. 2021; 121(4):2545-2647. PMC: 8836097. DOI: 10.1021/acs.chemrev.0c01122. View

Stefani M . Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta. 2004; 1739(1):5-25. DOI: 10.1016/j.bbadis.2004.08.004. View

Carpenter J, Randolph T, Jiskoot W, Crommelin D, Middaugh C, Winter G . Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci. 2008; 98(4):1201-5. PMC: 3928042. DOI: 10.1002/jps.21530. View

10.

Pham N, Meng W . Protein aggregation and immunogenicity of biotherapeutics. Int J Pharm. 2020; 585:119523. PMC: 7362938. DOI: 10.1016/j.ijpharm.2020.119523. View

11.

Wang W . Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm. 2005; 289(1-2):1-30. DOI: 10.1016/j.ijpharm.2004.11.014. View

12.

Kalita P, Tripathi T, Padhi A . Computational Protein Design for COVID-19 Research and Emerging Therapeutics. ACS Cent Sci. 2023; 9(4):602-613. PMC: 10042144. DOI: 10.1021/acscentsci.2c01513. View

13.

Siepen J, Westhead D . The fibril_one on-line database: mutations, experimental conditions, and trends associated with amyloid fibril formation. Protein Sci. 2002; 11(7):1862-6. PMC: 2373654. DOI: 10.1110/ps.0204302. View

14.

Benson D, Lipman D, Ostell J, Rapp B, Wheeler D . GenBank. Nucleic Acids Res. 1999; 28(1):15-8. PMC: 102453. DOI: 10.1093/nar/28.1.15. View

15.

Bairoch A, Apweiler R . The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 1999; 28(1):45-8. PMC: 102476. DOI: 10.1093/nar/28.1.45. View

16.

Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

17.

Thompson M, Sievers S, Karanicolas J, Ivanova M, Baker D, Eisenberg D . The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A. 2006; 103(11):4074-8. PMC: 1449648. DOI: 10.1073/pnas.0511295103. View

18.

Sawaya M, Sambashivan S, Nelson R, Ivanova M, Sievers S, Apostol M . Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007; 447(7143):453-7. DOI: 10.1038/nature05695. View

19.

Louros N, Konstantoulea K, De Vleeschouwer M, Ramakers M, Schymkowitz J, Rousseau F . WALTZ-DB 2.0: an updated database containing structural information of experimentally determined amyloid-forming peptides. Nucleic Acids Res. 2019; 48(D1):D389-D393. PMC: 6943037. DOI: 10.1093/nar/gkz758. View

20.

Shobana R, Pandaranayaka E . ProADD: A database on Protein Aggregation Diseases. Bioinformation. 2014; 10(6):390-2. PMC: 4110434. DOI: 10.6026/97320630010390. View